Citadel Advisors
SZYM

Citadel Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Citadel Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-75,300
Closed -$153K – 7906
2016
Q1 		$153K Sell
75,300
-41,300
-35% -$73.7K ﹤0.01% 5820
2015
Q4 		$289K Buy
116,600
+24,400
+26% +$72.4K ﹤0.01% 5268
2015
Q3 		$240K Buy
92,200
+57,800
+168% +$151K ﹤0.01% 5894
2015
Q2 		$108K Sell
34,400
-70,700
-67% -$242K ﹤0.01% 7009
2015
Q1 		$301K Sell
105,100
-500
-0.5% -$1.28K ﹤0.01% 5643
2014
Q4 		$272K Buy
105,600
+56,100
+113% +$245K ﹤0.01% 5582
2014
Q3 		$369K Sell
49,500
-4,700
-9% -$43.9K ﹤0.01% 5018
2014
Q2 		$638K Buy
54,200
+14,600
+37% +$156K ﹤0.01% 4084
2014
Q1 		$460K Sell
39,600
-3,200
-7% -$37.7K ﹤0.01% 4455
2013
Q4 		$466K Buy
42,800
+27,800
+185% +$274K ﹤0.01% 4110
2013
Q3 		$162K Sell
15,000
-75,300
-83% -$858K ﹤0.01% 4963
2013
Q2 		$1.06M Buy
+90,300
New +$902K ﹤0.01% 3139

Citadel Advisors's SZYM Position: Q2 2016 in Review

Citadel Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 47,587 shares — an estimated $97K sold.

Citadel Advisors first reported a position in SZYM in Q2 2013 and held it in 10 quarters. The position peaked at $678K in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Citadel Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Citadel Advisors sold 47,587 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $97K.
  • Citadel Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 10 quarters.
  • Citadel Advisors's SOLAZYME INC COM STK (DE) position peaked at $678K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.